Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyKarim Fizazi, Johann S. de Bono, Arturo Molina et al.|The Lancet Oncology|2012Cited by 1.4k
Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5Ranjana Mitra, Oscar B. Goodman|BMC Cancer|2017Cited by 72